SmartNotes. Thermo Scientific Specimen Validity Tests for Drugs of Abuse Testing

Similar documents
Thermo Scientific complete automated drugs of abuse testing solution

SmartNotes. Understanding the SAMHSA Guidelines for Drugs of Abuse Testing

Dilute Urine Samples: Response to Low Creatinine Specimens. By: Paul L. Cary Independent Forensic Toxicology Consultant

Best Practices Review Drug & Alcohol Testing. By: Paul L. Cary Independent Forensic Toxicology Consultant

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

Drug Testing: How to Evaluate Results

Rapid Alcohol Screening Devices. p19

2013 Clinical drug and alcohol testing solutions. Product Catalog. CLIA-waived point of care test devices

INCENTIVES, Sanctions and Therapeutic Responses BEST PRACTICE STANDARDS IN A NUTSHELL HELEN HARBERTS

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

SmartNotes. Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts

NEW YORK STATE DEPARTMENT OF HEALTH CLINICAL LABORATORY EVALUATION PROGRAM

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management

DRUG TESTS S: THEIR USES AND LIMITATIONS

You Can t Fool the Bladder Police. Effective Use of Urine Drug Screening

Best Practices Review Drug & EtG/EtS Testing. By: Paul L. Cary Independent Forensic Toxicology Consultant

Testing for Controlled Substances

Zinc Reduces the Detection of Cocaine, Methamphetamine, and THC by ELISA Urine Testing

EDUCATIONAL COMMENTARY METHADONE

13. Forensic Toxicology, Workplace Testing, Sports Medicine and Related Areas

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Payment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED:

SmartNotes. Thermo Scientific Oral Fluid Assays for Drug Testing in the Workplace. Oral Fluids for Workplace Testing

T R A I N I N G G U I D E

THE EFFECTIVENESS OF THE ALERE ISCREEN URINE ADULTERATION TEST STRIP AT DETECTING SIX COMMON URINE ADULTERANTS. Carrie Beard

EVERYTHING YOU WANTED TO KNOW ABOUT DRUG TESTING

The Truth about UA s (From the Trenches)

BEST PRACTICES IN DRUG TESTING National TASC Conference

Beating Drug Tests and Defending Positive Results

CLIA Regulations and Toxicology

A Best Practices Review Drug & Alcohol Testing. By: Paul L. Cary Independent Forensic Toxicology Consultant

Opiates Rapid Test. Cat. No.:DTS137 Pkg.Size:50T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Department of Health and Human Services

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

Cooking Meth and Doctor Shopping: The Challenges of Managing Prescription Therapeutics

OralTox instant oral fluid drug testing

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None

Fastect II Drug Screen Dipstick Test Training and Certification Program

Product Catalog. Rapid Alcohol Screening Devices. p24. Rapid Urine Screening Devices. p4. Rapid Oral Fluid Screening Devices. p18

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None

Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections *

A Review of SAMHSA s Revised Alcohol Biomarkers (EtG/EtS) Advisory - Spring By: Paul L. Cary Toxicology Laboratory University of Missouri

Cutoff levels for hydrocodone in a blood test

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

Urine drug testing it s not always crystal clear

The Defined HHS/DOT Substituted Urine Criteria Validated Through a Controlled Hydration Study

NeoSal Oral Fluid Collection System Solutions for Forensic Drug Detection

DRI METHAQUALONE APPLICATION BECKMAN COULTER AU5800

Novel Spot Tests for Detecting the Presence of Zinc Sulfate in Urine, a Newly Introduced Urinary Adulterant to Invalidate Drugs of Abuse Testing

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

CEDIA OPIATE APPLICATION BECKMAN COULTER AU5800

Third Party Controls for Your Dade Behring Systems

Drug & Alcohol Testing in. Canada. Point of Care Testing

Controlled Substance Monitoring in the Age of the Opioid Epidemic

BENZODIAZEPINES / BZO

DRUGS OF ABUSE

Pain Management Drug Testing: A Laboratory Perspective

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

Monitoring and Toxicology National Behavioral Consortium Phoenix, AZ Tuesday, February 9, 2016

Drug Testing Technologies: Sweat Patch

Product Training & Certification

More Effective Drug Testing: Tools, Interpretation, and Challenges. Pharmacodynamics. Pharmacokinetics. Dose Blood Receptors Effects

MythBusters - Drug Testing Myths

Drug Testing Policy. Approved By 05/10/2017. Application This reimbursement policy applies to UnitedHealthcare Community Plan Medicaid products.

Effects of Stealtff Adulterant on Immunoassay Testing for Drugs of Abuse*

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

MEDICAL POLICY Drug Testing

Drug Screening: Things You Need to Know

Medical Affairs Policy

QMS TACROLIMUS APPLICATION BECKMAN COULTER AU480 /AU680 /AU5800

Drug Testing Index A comprehensive analysis of workplace drug use trends

The Effects of Adulterants and Selected Ingested Compounds on Drugs-of-Abuse Testing in Urine

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50

Why Drug Test in the Retail Industry? 2010 Retail Inventory Shrinkage 3. Employee Theft $16.2B (43.7%)

Clearing Up The Confusion About Substance Abuse Testing

Hair Drug Testing Drugs of Abuse Hair Testing

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Urine Drug Testing, Advantages and Disadvantages. Advantages

Efficiency Evaluation of Urine Collection Vessels with Impeded Urine Adulteration/Substance of Abuse (SOA) Rapid Detection Test Strips

Product Training & Certification

PROFESSIONALISM AND COMMENTARY. Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management

Urine Drug Testing Methods 3-5

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

NEPHROCHECK Calibration Verification Kit Package Insert

Rules and Regulations. Rules and Regulations

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Instructions for Performing In-Office Lab Tests

DRUG-CONJUGATES The drug buprenorphine is conjugated to protein and immobilized as a line on a membrane at the BUP location labeled on the device.

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager

Transcription:

DIAGNOSTICS s SmartNotes Thermo Scientific s for Drugs of Abuse ing for Urine Tampering Using s Urine is the most commonly used specimen for drugs of abuse testing. This is primarily because urine is readily available in large quantities and contains high concentrations of parent drugs and metabolites. It is hence, an accepted way of testing for specimen validity when monitoring for abused drugs whether within the workplace, criminal justice system (e.g. drug courts) or for compliance. 1 There is also scientific research that supports the well-established cutoffs used to determine whether drugs in the urine are above or below the cutoff. In general, human urine reflects drugs consumed within the past three days. Despite all the benefits and ease in testing urine specimens, urine samples are extremely susceptible to tampering 1, making it tempting for participants to either use adulterants or dilute their urine. Direct observation at collection may help combat post collection tampering of urine. Ways in which urine can be tampered with 1 Pre-collection Dilution: Consuming large quantities of water or fluids prior to collection (water loading, flushing, hydrating, etc.) Adulteration: Consuming products designed to enhance drug elimination or removal of drugs (Gold Seal, Clean n Clear, -Free, Naturally Klean, etc.) Post-collection Dilution / Substitution: Adding clean urine to the specimen or exchanging urine for such common substitutes as apple juice and tea. Adulteration: Adding oxidizing agents which mask the presence of any drugs. [Nitrite (Klear ), Chromate (Urine Luck ), Iodine, Bleach, and Horse Radish Peroxidase/H2O2 (Stealth )]. What are s? Specimen validity tests (SVT) are methods used on a urine drug screen specimen to detect for substitution, adulteration, or dilution. Thermo Fisher Scientific provides Specimen Validity s for creatinine, specific gravity, oxidizing agents (e.g. nitrites) and ph. Adolescents who are chronic marijuana users, test positive with dip tests, even after 45 days. However, with creatinine normalization these results may test negative. It s crucial for drug courts to test specimen validity on every specimen to ensure they are getting a robust and accurate test result. - J. Carter, Specialized Docket Coordinator / Probation Officer, Mount Vernon Municipal Court, Ohio

The Thermo Scientific Solution : Thermo Scientific DRI -Detect is a waste product produced by the body and excreted in urine at a relatively constant rate. 2 Since creatinine is released at a constant rate, fluctuations in the level of creatinine in urine, may be an indication of hydration, dilution or substitution. If no creatinine is present in the specimen, the sample submitted may be substituted. A creatinine measurement below 20 mg/dl is rare and is a reliable indicator of an intentional effort at dilution or excessive fluid consumption (in general, unusual medical or metabolic conditions do not impact creatinine levels). 2,3 A creatinine measurement below 2 mg/dl is an indication of possible substitution. 2,3 However, drug levels can fluctuate with creatinine levels: more concentrated urine with a higher creatinine level could indicate increased drug usage, when in fact, the drug is just more concentrated. To get a true indication of drug usage, a creatinine adjustment should be performed. normalized drug levels help monitor drug usage and assure effectivity of drug court programs. (See page 3 for more details). Specific Gravity: Thermo Scientific DRI Gravity-Detect Specific gravity reflects the amount of solid particles that are dissolved in a urine sample. Concentrated urine will have a higher specific gravity, while the lower the specific gravity, the closer its consistency to water, indicating possible dilution and/or substitution. The normal range of specific gravity for urine is 1.003 to 1.030. 2,3 If a urine sample has a specific gravity of less than 1.003, then the sample is considered dilute and a specific gravity of 1.000 is essentially water. 2,3 Oxidizing Agents or Nitrites: Thermo Scientific DRI General Oxidant-Detect Oxidizing agents, when added to urine, do not show any significant change to the appearance of the urine and may not be detected by other methods such as ph, specific gravity or even creatinine concentration. 5 Several oxidizing adulterants are being sold with a claim to clear all positive drug test results. 3,6 The most commonly used oxidizing adulterants are nitrite (Klear ), chromate (Urine Luck ), iodine, bleach, and horseradish peroxidase (Stealth ). 3,5,6 Urine samples containing THC (Marijuana) and adulterated with oxidants such as nitrite may produce a positive result in the initial screen by immunoassay, but they may not be confirmed by GC/MS or LC-MS/MS. 5,6,9

ph: Thermo Scientific DRI ph-detect Normal urine should have a ph between 4.7-7.8. 4 Urine adulterated with bleach or ammonia will produce a basic ph (ph 11 or greater), while urine adulterated with lemon juice and vinegar will produce an acidic ph (ph 3 or lower). To confirm if specimens have not been diluted and/or adulterated, it is important to validate results using more than one specimen validity test, as just one of these tests cannot capture all methods of adulteration. If any of the urine parameters are outside the specified range, there should be reason to believe that the urine sample is adulterated. Characteristics of Normal Unadulterated Urine 2,3,4 : Temperature 32.5-37.7 C or 90.5-99.8 F ph within 4.7-7.8 Specific Gravity 1.003-1.030 80.0-200.0 mg/dl ing participant samples every time using multiple s allows you to create a historical map of the expected normal results for a particular participant. A deviation from the normal parameters is evidence of dilution or adulteration. For problematic participants with a history of relapse, urine specimens should be routinely tracked using various specimen validity tests. Doing so allows drug courts, and workplace testing or pain management clinicians to track participants and creates a powerful tool to help confront denial. At the end, testing urine samples for specimen validity ensures for a more effective drug monitoring program. *Creatine Adjusted Formula 2,7 : Drug concentrations in urine can be influenced by dilution (drinking large amounts of water) or dehydration. levels in the urine are a good indicator of this phenomena. 2,3 The higher the creatinine, the more concentrated the urine and vice versa. Adjustment, also referred to as Normalization, is used to normalize the creatinine concentration of urine to an expected average creatinine concentration. Once normalized, that concentration factor is used to normalize to the drug concentration. 8 Doing so corrects for fluctuations of urine concentration and provides a more robust understanding and interpretation of the drug concentration present in the urine specimen. 8 ing for creatinine, a commonly used specimen validity test, provides trend and historical data on average levels for specific individuals. This provides a more accurate assessment of drug concentration in urine due to sample dilution or substitution. 8 We ve used the following formula to determine Adjusted THC levels in the case studies discussed next. ( ) Directly Measured Drug Average Urine x = (100 mg/dl) Directly Measured (mg/dl) Normalized Drug

Case Study Mark and Mary are participants at their local state drug court and regularly come in for testing based on their testing schedule. The in-house drug court lab performs various tests based on their needs and the needs of their participants. The in-house lab tests Mark and Mary for THC and creatinine regularly on every visit. Below we share two ways to interpret data (semi-quantitative values) collected from Mark and Mary: Scenario 1: Mark is tested four different times and his THC concentrations are indicated in table 1 and plotted in graph 1. Mark s THC test results indicate that his THC concentrations are rising over time (blue line). However, when the results are adjusted for creatinine concentration, we observe that Mark s THC levels are actually decreasing over time (yellow line). Table 1 THC (mg/dl) Normalized THC * 1 45 81 56 2 58 120 48 3 70 160 44 4 80 195 41 Explanation: Consumption of fluids can play a critical role in determining urine drug concentration. Although within normal expected ranges for creatinine concentration, we observe that Mark s creatinine levels have increased significantly over time. Such an increase means Mark s urine is concentrated and hence his recorded THC concentration is high as well. When his drug levels are normalized to the creatinine levels, his THC drug test results are below the cutoff, suggesting that he was not taking the drug. Graph 1 ng/ml 90 80 70 60 50 40 30 20 THC Conc. 80 70 58 56 Cut off for THC 45 48 44 41 Adjusted THC Conc. 1 2 3 4 Scenario 2: Mary is tested four different times and her drug results are summarized in table 2 and plotted in graph 2. Mary s THC test results indicate that her THC concentrations are decreasing over time (blue line). However, when the results are adjusted for her creatinine concentration, we observe that Mary s THC levels are actually increasing over time (yellow line). Table 2 THC (mg/dl) Normalized THC * 1 52 75 69 2 45 60 75 3 38 50 76 4 25 40 63 Explanation: Urine dilution by excessive fluid consumption or substitution can play a major role in determining urine drug concentration. Although within close to normal ranges for Mary s creatinine concentration, we observe that her creatinine levels have decreased over time. Such a decrease means Mary s urine is dilute and hence her recorded THC concentration is low as well. In Mary s case, one can suspect continued use of marijuana, as her creatinine adjusted THC concentration is above the cutoff. Graph 2 ng/ml 80 70 60 50 40 30 20 75 76 69 63 Adjusted THC Conc. 52 Cut off for THC 45 38 THC Conc. 25 1 2 3 4

Product Information DRI -Detect Part Number Description Cut-off Level Kit Size 1797 10015638 100272 DRI -Detect DRI Indiko -Detect -Detect Calibrator Set 500 ml 3 x 18 ml 2.0 & 20 2 x 25 ml 100273 1.3 Control 1.3mg/dL 25 ml 100274 7.5 Control 7.5mg/dL 25 ml 100275 23.0 Control 23mg/dL 25 ml DRI Gravity-Detect Part Number Description Cut-off Level Kit Size 1194 10018532 DRI Gravity-Detect DRI Indiko Gravity-Detect 2 x 500 ml 6 x 18 ml 1754 Low Gravity Calibrator 1.010 2 x 25 ml 1755 High Gravity Calibrator 1.025 25 ml 1756 Level 1 Gravity Control 1.015 25 ml 1757 Level 2 Gravity Control 1.030 25 ml DRI General Oxidant-Detect Part Number Description Cut-off Level Kit Size DRI ph-detect Part Number Description ph Level Kit Size 10009958 10018528 10009971 10009972 DRI General Oxidant-Detect DRI Indiko General Oxidant-Detect General Oxidant-Detect Calibrator Set General Oxidant-Detect Control Set 2 x 500 ml 6 x 18 ml 0 & 200 2 x 25 ml 100 & 300 2 x 25 ml 100054 10015654 DRI ph-detect DRI Indiko ph-detect 2 x 500 ml 6 x 18 ml 100283 ph Calibrator Set 3.0 & 11.0 2 x 25 ml 10024403 ph Calibrator Set* 4.0 & 11.0 2 x 25 ml 100282 ph 3.6 Control 3.6 25 ml 10024083 ph 4.5 Control* 4.5 25 ml 100284 ph 7.0 Control 7.0 25 ml 100285 ph 10.0 Control 10 25 ml 100281 ph 11.5 Control 11.5 25 ml * Meets new SAMHSA Guidelines, Effective October 1st 2017.

References 1. Dasgupta, A. The Effects of Adulterants and Selected Ingested Compounds on Drugs-of-Abuse ing in Urine. American Journal of Clinical Pathology., U.S. National Library of Medicine, Sept. 2007, www.ncbi.nlm.nih.gov/pubmed/17709324. 2. Adult Drug Court Best Practice Standards. Volume II, NADCP, 2015, www.nadcp.org/standards. 3. Cone, E J, et al. Normalization of Urinary Drug s with Specific Gravity and. Journal of Analytical Toxicology., U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/19161663. 4. Thermo Scientific DRI ph-detect, Package Insert. 5. Dasgupta, A. How People Try to Beat Drug ing. AACC, Feb. 2015, www.aacc.org/publications/cln/articles/2015/february/ drug-testing.aspx. 6. Thermo Scientific DRI General Oxidant-Detect, Package Insert. 7. Yee, D A, et al. Observations on the Urine Metabolic Ratio of Oxymorphone to Oxycodone in Pain Patients. Journal of Analytical Toxicology., U.S. National Library of Medicine, May 2012, www.ncbi.nlm.nih.gov/pubmed/22511697. 8. Price, J W. Normalization of Workplace Urine Drug s: Does It Make a Difference? Journal of Addiction Medicine., U.S. National Library of Medicine, Mar. 2013, www.ncbi.nlm.nih.gov/pubmed/23370934. 9. Paul, B D, and C S Dunkley. ing (SVT) - Effects of Oxidizing Agents on Drugs in Urine and Procedures for Detection. Forensic Science Review., U.S. National Library of Medicine, July 2007, www.ncbi.nlm.nih.gov/pubmed/26247282. 10. Thermo Scientific DRI General Oxidant-Detect, Package Insert. 11. Thermo Scientific DRI -Detect, Package Insert. 12. Thermo Scientific DRI Gravity-Detect, Package Insert. In the United States: For customer service, call 1-800-232-3342 To fax an order, use 1-800-829-8115 To order online: mgc.customerservice@thermofisher.com Find out more at thermofisher.com/diagnostics 2018 Thermo Fisher Scientific Inc. All rights reserved. Urine Luck is a registered trademark of Spectrum Laboratories. Thermo Scientific, Indiko, DRI, Creatine-Detect, Gravity-Detect, ph-detect, General Oxidant-Detect, and the Thermo Fisher Scientific logo are the property of Thermo Fisher Scientific and its subsidiaries. Information and technical specifications are subject to change without notice. AN10021656-1MTL-Specimen-Validity-SmartNotes-EN 2018 02